Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$378M |
| 2 |
TJX Companies
TJX
|
+$346M |
| 3 |
Pfizer
PFE
|
+$336M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$317M |
| 5 |
Linde
LIN
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$536M |
| 3 |
Applied Materials
AMAT
|
+$524M |
| 4 |
Warner Bros
WBD
|
+$319M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.09% |
| 2 | Financials | 11.94% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EHI
3301
Western Asset Global High Income Fund
EHI
$175M
| $573K | ﹤0.01% |
54,537
-50,585
| -48% | -$518K |
|
3302
iShares JPMorgan EM Corporate Bond ETF
CEMB
$398M
| $572K | ﹤0.01% |
10,998
-27,657
| -72% | -$1.45M |
|
3303
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.4B
| $570K | ﹤0.01% |
5,202
-1,603
| -24% | -$178K |
|
3304
PMV Pharmaceuticals
PMVP
$60.3M
| $570K | ﹤0.01% |
17,319
+13,706
| +379% | +$540K |
|
3305
iShares MSCI Denmark ETF
EDEN
$209M
| $567K | ﹤0.01% |
5,856
-348
| -6% | -$33.6K |
|
|
MRC
3306
DELISTED
MRC Global
MRC
| $567K | ﹤0.01% |
62,814
-77,305
| -55% | -$658K |
|
3307
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.01B
| $567K | ﹤0.01% |
10,197
-22,667
| -69% | -$1.24M |
|
3308
Beyond Air
XAIR
$3.91M
| $567K | ﹤0.01% |
258
-125
| -33% | -$303K |
|
|
DRNA
3309
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $564K | ﹤0.01% |
22,063
-29,929
| -58% | -$764K |
|
|
IGA
3310
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
| $563K | ﹤0.01% |
58,734
-12,798
| -18% | -$115K |
|
|
KE
3311
Kimball Electronics
KE
$591M
| $563K | ﹤0.01% |
21,805
-10,980
| -33% | -$250K |
|
|
RPT
3312
Rithm Property Trust
RPT
$97.2M
| $563K | ﹤0.01% |
8,603
+64
| +0.7% | +$4.24K |
|
3313
Cerus
CERS
$579M
| $562K | ﹤0.01% |
93,443
-2,000
| -2% | -$13.6K |
|
|
CBH
3314
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
| $560K | ﹤0.01% |
54,014
-31,748
| -37% | -$321K |
|
3315
PTC Therapeutics
PTCT
$6.26B
| $559K | ﹤0.01% |
11,807
-15,805
| -57% | -$939K |
|
3316
Republic Bancorp
RBCAA
$1.93B
| $558K | ﹤0.01% |
12,579
-2,300
| -15% | -$95.2K |
|
3317
Chunghwa Telecom
CHT
$33.1B
| $555K | ﹤0.01% |
14,171
+6,388
| +82% | +$251K |
|
|
HTD
3318
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$915M
| $555K | ﹤0.01% |
23,624
-2,311
| -9% | -$49.8K |
|
|
CAPD
3319
DELISTED
iPath Shiller CAPE ETN
CAPD
| $555K | ﹤0.01% |
28,950
-19,160
| -40% | -$354K |
|
3320
Retractable Technologies
RVP
$20.1M
| $554K | ﹤0.01% |
43,232
-73,572
| -63% | -$1.06M |
|
3321
Shinhan Financial Group
SHG
$34B
| $554K | ﹤0.01% |
16,553
+1,247
| +8% | +$37.8K |
|
3322
Amalgamated Financial
AMAL
$1.48B
| $547K | ﹤0.01% |
32,996
-14,171
| -30% | -$230K |
|
3323
ORIX
IX
$44.1B
| $544K | ﹤0.01% |
32,100
+6,125
| +24% | +$105K |
|
3324
CorMedix
CRMD
$588M
| $542K | ﹤0.01% |
54,195
+32,805
| +153% | +$345K |
|
|
SHLX
3325
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $542K | ﹤0.01% |
40,650
-12,018
| -23% | -$142K |
|
Similar funds
Ameriprise's Q1 2021 Portfolio in Review
As of Q1 2021, Ameriprise held 3,961 positions worth $301B, up 6.7% from $282B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q1 2021 filing shows 208 new, 1,854 increased, 1,673 reduced and 132 closed positions. Its largest new stake was ON24: 907,983 shares worth $44M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2021 buy was ON24: 907,983 shares worth $44M.
- Ameriprise added most to RTX Corp in Q1 2021, an estimated $378M increase.
- Ameriprise's biggest Q1 2021 reduction was Apple, cutting an estimated $1.19B.
- Ameriprise fully exited WPX Energy, Inc. in Q1 2021, selling an estimated $75.9M.
- Ameriprise's ten largest holdings make up 15% of its $301B portfolio in Q1 2021.
- Ameriprise opened 208 new positions and closed 132 in Q1 2021.
- Ameriprise's portfolio value rose 6.7% quarter-over-quarter to $301B.
Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.